1-9 of 9
Kerry Savage
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)

Free
Solomon Abate, Steven Huang, Elysha Vanderveer, Diego Villa, Christopher Venner, David Scott, Kerry Savage, Laurie Sehn, Cynthia Toze, Alina Gerrie
Journal: Blood
Blood (2025) 146 (Supplement 1): 2748.
https://doi.org/10.1182/blood-2025-2748
Published: 2025
Journal Articles

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Free
Andree-Anne Pelland, Jonathan Isenberg, Rayan Ramadan, Alina Gerrie, Kerry Savage, Laurie Sehn, David Scott, Diego Villa, Anna Nguyen, Ashley Freeman, Lynda Foltz, Khaled Ramadan, Robert Schmidt, Florian Kuchenbauer, Ardashes Avanessian, Erma Gardner, Afsaneh Panahi, Jesse Shustik, Kevin Song, Christopher Venner
Journal: Blood
Blood (2025) 146 (Supplement 1): 5806.
https://doi.org/10.1182/blood-2025-5806
Published: 2025
Journal Articles

External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials

Free
Angie Mae Rodday, Dennis Eichenauer, Janina Jablonski, Sven Borchmann, Hocine Tighiouart, Jenica Upshaw, David Hodgson, Matthew Maurer, Nicholas Counsell, Sara Rossetti, Zhu Cui, Ranjana Advani, Marc Andre, Massimo Federico, Annette Hay, Richard Hoppe, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, Kerry Savage, John Radford, James Cerhan, Peter Borchmann, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 1845.
https://doi.org/10.1182/blood-2025-1845
Published: 2025
Journal Articles

Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P

Free
Zachary Epstein-Peterson, Nivetha Ganesan, Christina Poh, Ranjana Advani, Umut Aypar, Bryce Bowler, Ellie Casper, Tiffany Chang, Ahmet Dogan, Ozgur Can Eren, Tatyana Feldman, Natasha Galasso, Vaishali Gautam, Paola Ghione, Sarvarinder Gill, Kelly Hannigan, Jonathan Isenberg, Swami Iyer, Katie Ksanznak, Andrew Lytle, Jonathan Moreira, Alison Moskowitz, Ranjit Nair, Timothy Oh, Evelyn Orlando, Jia Ruan, Kerry Savage, Graham Slack, Robert Stuver, Jessie Xu, Austin Yeung, Jasmine Zain, Yanming Zhang, Steven Horwitz
Journal: Blood
Blood (2025) 146 (Supplement 1): 5410.
https://doi.org/10.1182/blood-2025-5410
Published: 2025
Journal Articles

Long-term outcomes of patients with hairy cell leukemia treated with first-line cladribine in British Columbia

Free
Jonathan Isenberg, Kerry Savage, David Scott, Laurie Sehn, Christopher Venner, Diego Villa, Alina Gerrie
Journal: Blood
Blood (2025) 146 (Supplement 1): 1805.
https://doi.org/10.1182/blood-2025-1805
Published: 2025
Journal Articles

PET imaging biomarkers predict survival in peripheral T-cell lymphoma: A systematic review and meta-analysis.

Free
Lohitha Dhulipalla, Tapasya Raavi, Meghana Pattipati, Kai Wang, Monika Karki, Sihle Mabhida, Luis Malpica, Ranjit Nair, Luis Fayad, Neha Mehta-Shah, Ranjana Advani, Kerry Savage, Steven Horwitz, Maria Rodriguez, F. B. Hagemeister, Swami Iyer
Journal: Blood
Blood (2025) 146 (Supplement 1): 6299.
https://doi.org/10.1182/blood-2025-6299
Published: 2025
Journal Articles

PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course

Free
Zhu Cui, Angie Mae Rodday, Hocine Tighiouart, Nicholas Counsell, Sara Rossetti, Jenica Upshaw, Amy Kirkwood, Hongli Li, Ranjana Advani, Olivier Casasnovas, James Cerhan, Massimo Federico, Andrea Gallamini, Herve Ghesquieres, Eliza Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, John Radford, Kerry Savage, Deborah Stephens, Pier Luigi Zinzani, Matthew Maurer, Cedric Rossi, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 129.
https://doi.org/10.1182/blood-2025-129
Published: 2025
Journal Articles

A Phase II Study of Enzastaurin, a Protein Kinase C-β (PKCβ) Inhibitor, in the Treatment of Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).

Free
Michael Robertson, Brad Kahl, Julie Vose, Sven de Vos, Mary Laughlin, Patrick Flynn, Kendrith Rowland, Jose Cruz, Stuart Goldberg, Christelle Darnstein, Nathan Enas, Donna Neuberg, Kerry Savage, Donald Thornton, Christopher Slapak, Margaret Shipp
Journal: Blood
Blood (2005) 106 (11): 934.
https://doi.org/10.1182/blood.V106.11.934.934
Published: 2005
Journal Articles

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Free
Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Catherine Fitzgerald, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Kenneth Wilson, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2005) 106 (11): 492.
https://doi.org/10.1182/blood.V106.11.492.492
Published: 2005